DXR

$8.70-3.33%visit website

DAXOR CORP

Market Cap

$51M

Live price × Finnhub shares (2026-10-17)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.40

60mo monthly vs SPY

P/E (TTM)

—

No recent SEC filing data

No 10-Q/10-K since Mar 28, 2012

P/S (TTM)

—

No recent SEC filing data

No 10-Q/10-K since Mar 28, 2012

P/B

—

No recent SEC filing data

No 10-Q/10-K since Mar 28, 2012

EV/EBITDA (TTM)

—

No recent SEC filing data

No 10-Q/10-K since Mar 28, 2012

Loading…

Financial Statements

USD thousands	Dec 2010 Dec 31, 2010	Q2 FY2011 Jun 30, 2011	Q3 FY2011 Sep 30, 2011	Q4 FY2011 Dec 31, 2011	TTM Dec 31, 2011
Revenue	361	358	341	370	1,446
Cost of revenue	185	161	149	177	653
Gross profit	177	197	192	193	794
Research & development	720	670	637	710	2,706
Selling, general & administrative	983	871	816	489	3,874
Total operating expenses	1,704	1,541	1,453	1,198	6,580
Operating income	(1,527)	(1,344)	(1,261)	(1,006)	(5,786)
Interest expense		81.3	29.8
Income tax	1,039	(182)	(2,845)	(1,055)	(5,142)
Net income	2,268	(185)	(4,184)	(1,491)	(7,186)
EPS (basic) ($)		(0.04)	(0.99)		(1.70)
EPS (diluted) ($)		(0.04)	(0.99)		(1.70)
Weighted avg. shares (basic)		4,225	4,219

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-K filed Mar 28, 2012, period ended Dec 31, 2011. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 2 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

3 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Jun 24, 2026 accepted 8:10 PM ET	5.07Shareholder vote	Document SEC ↗
Jan 26, 2026 accepted 9:58 PM ET	1.01Material agreement8.01Other events	Document SEC ↗
Jan 23, 2026 accepted 11:09 AM ET	8.01Other events	Document SEC ↗
Aug 7, 2025 accepted 12:26 PM ET	8.01Other events	Document SEC ↗
Jul 1, 2025 accepted 2:52 PM ET	5.07Shareholder vote	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

13%

W/W +8.5pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-04-08	2026-04-10	Feldschuh Michael Richard	Director & Chief Executive Officer	Purchase	1,000	$9.07	$9K	213.7K	View
2026-03-31	2026-03-31	Michel Robert J	Chief Financial Officer	Purchase	1,000	$9.90	$10K	21.1K	View
2026-03-20	2026-03-24	Jefferies John	Chief Medical Officer	Purchase	5,941	$0.00	—	23.6K	View